Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 September 1995 | Volume 123 Issue 5 | Pages 338-343
Objective: To evaluate 1) the hemorrheologic and hemodynamic effects of glyceryl trinitrate in patients with non-insulin-dependent diabetes mellitus and 2) the influence of antioxidants on these effects.
Design: Case-control study.
Setting: University hospital clinic.
Patients: 40 patients with diabetes and no evidence of cardiovascular complications and 40 controls matched for demographic variables and body habitus.
Interventions: Sublingual glyceryl trinitrate (0.3 mg) and transdermal glyceryl trinitrate patches (10 mg/d). Vitamin E, 300 mg/d orally for 7 days, and glutathione, 600 mg intravenously or intramuscularly, were given to test the effects of antioxidant supplementation.
Measurements: Systolic, diastolic, and mean arterial pressure and heart rate; left ventricular ejection fraction; platelet aggregation, blood viscosity, and blood filterability in vitro and ex vivo.
Results: Compared with controls, patients with diabetes had increased platelet aggregation to adenosine diphosphate (P < 0.005), increased blood viscosity (P < 0.001), and decreased blood filterability (P = 0.041) at baseline; blood pressure, heart rate, and ejection fraction were similar in the two groups. In controls, both sublingual glyceryl trinitrate and transdermal glyceryl trinitrate patches significantly reduced platelet aggregation (38%; 95% CI, 49% to 27%) and blood viscosity (8%; CI, 11% to 5%) and increased blood filterability (10%; CI, 7.0% to 13.1%). Slight but significant decreases in blood pressure and ejection fraction and an increase in heart rate were also seen in controls after administration of glyceryl trinitrate (both preparations). In patients with diabetes, glyceryl trinitrate paradoxically increased platelet aggregation (24%; CI, 15% to 33%) and blood viscosity (6%; CI, 2.9% to 8.8%) and decreased blood filterability (7%; CI, 9.5% to 4.4%); hemodynamic values did not change significantly. In both groups, rheologic responses to glyceryl trinitrate (end concentration, 100 and 200 ng/mL) in vitro were similar to those seen in ex vivo studies. Vitamin E and glutathione normalized rheologic responses to glyceryl trinitrate in patients with diabetes.
Conclusions: Organic nitrates have beneficial effects on blood rheology in controls but not in patients with diabetes, in whom a paradoxical deterioration is seen. Antioxidant supplementation can normalize primary tolerance to the rheologic effects of nitrates in diabetes.
Author and Article Information
From the Second University of Naples and the Diabetic Clinic Lepanto, Naples, Italy; and the Diabetic Clinic Santa Rita, Taranto, Italy.
ARTICLE
Abnormal Rheologic Effects of Glyceryl Trinitrate in Patients with Non-Insulin-Dependent Diabetes Mellitus and Reversal by Antioxidants
![]()
Requests for Reprints: Dario Giugliano, MD, Via Emilia 1, 80021 Afragola, Italy.
Current Author Addresses: Drs. Giugliano, Marfella, Verrazzo, Coppola, D'Onofrio: Department of Geriatrics and Metabolic Disease, Second University of Naples, Piazza L. Miraglia, 80138 Napoli, Italy.
This article has been cited by other articles:
![]() |
Y. Y. Chirkov, A. S. Holmes, S. R. Willoughby, S. Stewart, R. D. Wuttke, P. R. Sage, and J. D. Horowitz Stable angina and acute coronary syndromes are associated with nitric oxide resistance in platelets J. Am. Coll. Cardiol., June 1, 2001; 37(7): 1851 - 1857. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Nappo, N. De Rosa, R. Marfella, D. De Lucia, D. Ingrosso, A. F. Perna, B. Farzati, and D. Giugliano Impairment of Endothelial Functions by Acute Hyperhomocysteinemia and Reversal by Antioxidant Vitamins JAMA, June 9, 1999; 281(22): 2113 - 2118. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Giugliano, R. Marfella, H. Watanabe, M. Kakihana, S. Ohtsuka, and Y. Sugishita Antioxidants and Nitrate Tolerance • Response Circulation, September 29, 1998; 98(13): 1350 - 1353. [Full Text] [PDF] |
||||
![]() |
G. M. Pieper Review of Alterations in Endothelial Nitric Oxide Production in Diabetes : Protective Role of Arginine on Endothelial Dysfunction Hypertension, May 1, 1998; 31(5): 1047 - 1060. [Full Text] [PDF] |
||||
![]() |
D. Giugliano, R. Marfella, L. Coppola, G. Verrazzo, R. Acampora, R. Giunta, F. Nappo, C. Lucarelli, and F. D'Onofrio Vascular Effects of Acute Hyperglycemia in Humans Are Reversed by L-Arginine : Evidence for Reduced Availability of Nitric Oxide During Hyperglycemia Circulation, April 1, 1997; 95(7): 1783 - 1790. [Abstract] [Full Text] |
||||
![]() |
Nitroglycerin Less Effective for Diabetics with CHD? Journal Watch Cardiology, October 1, 1995; 1995(1001): 9 - 9. [Full Text] |
||||